Jean-Philippe Coppé

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Nature cancer

Nature cell biology

This page only lists publications with an associated author ORCID identifier.

Publications

Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Qiang Sun, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spassov, Eleanor Fewings, Y Christina Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M Wolf, Byron Hann, Scott R VandenBerg, Kevan M Shokat, Mark M Moasser, René Bernards, Jorge Silvio Gutkind, Laura van 't Veer, Jean-Philippe Coppé
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF V600E colorectal tumors. Nature cancer 4 (2) (2023)
Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Qiang Sun, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spassov, Eleanor Fewings, Y Christina Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M Wolf, Byron Hann, Scott R VandenBerg, Kevan M Shokat, Mark M Moasser, René Bernards, Jorge Silvio Gutkind, Laura van 't Veer, Jean-Philippe Coppé
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF V600E colorectal tumors. Nature cancer (2023)
Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Qiang Sun, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spassov, Eleanor Fewings, Y Christina Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M Wolf, Byron Hann, Scott R VandenBerg, Kevan M Shokat, Mark M Moasser, René Bernards, Jorge Silvio Gutkind, Laura van 't Veer, Jean-Philippe Coppé
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF V600E colorectal tumors. Nature cancer (2023)
Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Qiang Sun, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spassov, Eleanor Fewings, Y Christina Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M Wolf, Byron Hann, Scott R VandenBerg, Kevan M Shokat, Mark M Moasser, René Bernards, Jorge Silvio Gutkind, Laura van 't Veer, Jean-Philippe Coppé
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF V600E colorectal tumors. Nature cancer 4 (2) (2023)
Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Qiang Sun, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spassov, Eleanor Fewings, Y Christina Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M Wolf, Byron Hann, Scott R VandenBerg, Kevan M Shokat, Mark M Moasser, René Bernards, Jorge Silvio Gutkind, Laura van 't Veer, Jean-Philippe Coppé
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF V600E colorectal tumors. Nature cancer 4 (2) (2023)
Ana Ruiz-Saenz, Chloe E Atreya, Changjun Wang, Qiang Sun, Courtney A Dreyer, Diede Brunen, Anirudh Prahallad, Denise P Muñoz, Dana J Ramms, Valeria Burghi, Danislav S Spassov, Eleanor Fewings, Y Christina Hwang, Cynthia Cowdrey, Christina Moelders, Cecilia Schwarzer, Denise M Wolf, Byron Hann, Scott R VandenBerg, Kevan M Shokat, Mark M Moasser, René Bernards, Jorge Silvio Gutkind, Laura van 't Veer, Jean-Philippe Coppé
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAF V600E colorectal tumors. Nature cancer 4 (2) (2023)
Jean-Philippe Coppé, Miki Mori, Bo Pan, Christina Yau, Denise M Wolf, Ana Ruiz-Saenz, Diede Brunen, Anirudh Prahallad, Paulien Cornelissen-Steijger, Kristel Kemper, Christian Posch, Changjun Wang, Courtney A Dreyer, Oscar Krijgsman, Pei Rong Evelyn Lee, Zhongzhong Chen, Daniel S Peeper, Mark M Moasser, René Bernards, Laura J van 't Veer
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilities. Nature cell biology 21 (6) (2019)

Jean-Philippe Coppé.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jean-Philippe Coppé